Cost-effectiveness analysis of blood cell separators in allogeneic hematopoietic stem cell transplantation: a perspective from the Chinese healthcare system
Higher CE of the apheresis system optimizes both healthcare resource consumption and clinical outcomes. In the analysis considering the device price, Spectra Optia achieved cost-effectiveness dominance over COM.TEC at a surgical volume exceeding 121 cases per device.
Authors
- Xiangyan Tang (ORCID: https://orcid.org/0009-0002-9239-6155)
- Wenxi Tang (ORCID: https://orcid.org/0000-0002-3564-3626)
- Mingye Zhao (ORCID: https://orcid.org/0000-0002-7709-9374)
- Dun‐hua Zhou (ORCID: https://orcid.org/0000-0003-0179-5223)
- Hongshu Fang
- Ke Wang (ORCID: https://orcid.org/0000-0002-1763-6385)
Institutions
- China Pharmaceutical University (CN)
Publication Details
- Journal
- International Journal of Technology Assessment in Health Care
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1017/s0266462325103218
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00